|
FAM120AOS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.18239999966374E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.52319999946471E-08 |
| Normal-vs-Stage2 |
1.455530E-02 |
| Normal-vs-Stage3 |
6.966100E-02 |
| Normal-vs-Stage4 |
9.847600E-01 |
| Stage1-vs-Stage2 |
8.925000E-01 |
| Stage1-vs-Stage3 |
8.644800E-03 |
| Stage1-vs-Stage4 |
3.82700000000069E-05 |
| Stage2-vs-Stage3 |
1.632430E-01 |
| Stage2-vs-Stage4 |
2.250400E-02 |
| Stage3-vs-Stage4 |
1.614780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.44929999948518E-07 |
| Normal-vs-AfricanAmerican |
5.348000E-01 |
| Normal-vs-Asian |
2.227000E-01 |
| Caucasian-vs-AfricanAmerican |
1.192500E-02 |
| Caucasian-vs-Asian |
3.349400E-01 |
| AfricanAmerican-vs-Asian |
2.679000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.344970E-03 |
| Normal-vs-Female |
3.07490000017729E-07 |
| Male-vs-Female |
7.779800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.515400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.10609999954315E-07 |
| Normal-vs-Age(61-80Yrs) |
2.397800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.204800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.516000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.260600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.329400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.495700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.014200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.604600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.411750E-01 |
| Normal-vs-Grade 2 |
1.67970000131135E-08 |
| Normal-vs-Grade 3 |
2.241800E-03 |
| Normal-vs-Grade 4 |
9.041200E-01 |
| Grade 1-vs-Grade 2 |
8.383400E-01 |
| Grade 1-vs-Grade 3 |
6.907600E-01 |
| Grade 1-vs-Grade 4 |
1.626620E-01 |
| Grade 2-vs-Grade 3 |
8.199800E-02 |
| Grade 2-vs-Grade 4 |
1.102670E-03 |
| Grade 3-vs-Grade 4 |
7.300100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.17440510041911E-11 |
| Normal-vs-ccB subtype |
1.542600E-01 |
| ccA subtype-vs-ccB subtype |
2.93229999948075E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.007540E-04 |
| Normal-vs-N1 |
4.328400E-01 |
| N0-vs-N1 |
8.997800E-01 |
|
|
